The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk

Heart

Volumn 99, Issue 13, 2013, Pages 914-920

  Fairbairn, Timothy A ^a   Meads, David M ^a   Hulme, Claire ^a   Mather, Adam N ^a   Plein, Sven ^a   Blackman, Daniel J ^b   Greenwood, John P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ENDOCARDITIS; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK PATIENT; HOSPITALIZATION COST; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; LENGTH OF STAY; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RENAL REPLACEMENT THERAPY; SURGICAL RISK; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; UNITED KINGDOM; VASCULAR DISEASE;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION TREES; GREAT BRITAIN; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MARKOV CHAINS; MODELS, ECONOMIC; MONTE CARLO METHOD; POSTOPERATIVE COMPLICATIONS; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; SEVERITY OF ILLNESS INDEX; STATE MEDICINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878785874     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-303722     Document Type: Article

References (33)

1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11. (Pubitemid 44353666)
2. Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009;373:956-66.
3. Pellikka PA. Outcome of 622 Adults With Asymptomatic, Hemodynamically Significant Aortic Stenosis During Prolonged Follow-Up. Circulation 2005;111:3290-5. (Pubitemid 40875002)
4. Kvidal P, Bergstrom R, Horte LG, et al. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000;35:747-56. (Pubitemid 30167033)
5. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20. (Pubitemid 41746694)
6. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.
7. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
8. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012;366:1686-95.
9. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ 2004;13:1203-10. (Pubitemid 40017242)
10. Reed SD, Anstrom KJ, Bakhai A, et al. Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. Am Heart J 2005;149:434-43. (Pubitemid 40585405)
11. Fairbairn TA, Meads DM, Mather AN, et al. Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes. J Am Coll Cardiol 2012;59:1672-80.
12. Kind P HG, Macran S. UK Population norms for EQ-5D. York Centre for Health Economics. 1999 1999;University of York.
13. Caro JJ, Guo S, Ward A, et al. Modelling the economic and health consequences of cardiac resynchronization therapy in the UK. Curr Med Res Opin 2006;22:1171-9. (Pubitemid 44000737)
14. Maliwa MA, van der Heijden GJ, Bots ML, et al. Quality of life and NYHA class 30 years after mechanical aortic valve replacement. Cardiovasc Surg 2003;11:381-7. (Pubitemid 37076010)
15. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-87. (Pubitemid 34041389)
16. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. European Heart Journal 2010;32:198-204.
17. Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012;98:370-6.
18. Reynolds MR, Magnuson EA, Lei Y, et al. Cost-Effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with Ssvere aortic stenosis: Results of the PARTNER (Placement of Aortic Transcatheter Valves) Trial (Cohort A). J Am Coll Cardiol 2012;60:2683-92.
19. Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012;2(3).
20. Doble B, Blackhouse G, Goeree R, et al. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective. J Thorac Cardiovasc Surg 2012.
21. Dimarakis I, Rehman SM, Grant SW, et al. Conventional aortic valve replacement for high-risk aortic stenosis patients not suitable for trans-catheter aortic valve implantation: feasibility and outcome. Eur J Cardiothorac Surg 2011;40:743-8.
22. Reynolds MR, Magnuson EA, Wang K, et al. Cost-Effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results From the Placement of Aortic Transcatheter Valves (PARTNER) Trial (Cohort B). Circulation 2012;125:1102-9.
23. Buellesfeld L, Gerckens U, Schuler G, et al. 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol 2011;57:1650-7.
24. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011;123:299-308.
25. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011;32:198-204.
26. Luengo-Fernandez R, Gray AM, Rothwell PM. Costs of stroke using patient-level data: a critical review of the literature. Stroke 2009;40:e18-23.
27. Brennan A, Kharroubi S, O'Hagan A, et al. Calculating partial expected value of perfect information via Monte Carlo sampling algorithms. Med Decis Making 2007;27:448-70. (Pubitemid 47106943)
28. Curtis L. Unit Costs of Health and Social Care. Personal Social Services Research Unit. 2011. http://www.pssru.ac.uk/archive/pdf/uc/uc2011/uc2011.pdf (accessed 14 Feb 2013).
29. Britain. BMAaRPSoG. British National Formulary. BMA 2011;61.
30. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-8.
31. Solomon NA, Glick HA, Russo CJ, et al. Patient preferences for stroke outcomes. Stroke 1994;25:1721-5. (Pubitemid 24274961)
32. Morgan SL, McEwan P, Morrissey M, et al. Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications. Diabet Med 2006;23:1100-5. (Pubitemid 44401139)
33. Lee AJ, Morgan CL, Conway P, et al. Characterisation and comparison of health-related quality of life for patients with renal failure. Curr Med ResOpin 2005;21:1777-83. (Pubitemid 41667245)